Latest Mergers And Acquisitions News

Great Divide Mining Ltd has taken a decisive step from explorer to gold producer by securing a farm-in agreement for the Adelong Gold Project and raising $2.05 million to fund production restart and exploration activities.

FireFly Metals reports robust March quarter results, highlighting significant drilling success at its Green Bay Copper-Gold Project and a well-funded position to advance large-scale mining studies.

Lark Distilling Co. reported a robust Q3FY25 with net sales rising 31% to $4.3 million, driven by growth in travel retail, ecommerce, and exclusive whisky releases. The company also progressed its Pontville distillery redevelopment and maintained positive operating cash flow.

Top End Energy has completed its strategic acquisition of Serpentine Energy, significantly expanding its natural hydrogen footprint in Kansas and advancing towards its first well drilling, while also progressing exploration in Australia’s Northern Territory.

Island Pharmaceuticals has completed dosing in the Phase 2b cohort of its dengue fever trial, with pharmacokinetic targets met and top-line results expected next month. The company also strengthened its balance sheet by raising $1.94 million through option exercises.

Top End Energy Limited reported a mixed quarterly cash flow with operating and investing outflows offset by robust financing inflows, ending March 2025 with over five quarters of funding available.

PeopleIn Limited reported a $6.3 million Q3 FY25 EBITDA, down from $6.9 million last year, affected by severe weather in Queensland. Strong cash flow helped reduce debt, underscoring resilience despite ongoing trading challenges.

Airtasker Limited has reported a robust 3Q25 with positive free cash flow and remarkable revenue growth in its UK and US marketplaces, signalling strong momentum in its international expansion.

NOVONIX has signed a definitive agreement to acquire a large parcel in Chattanooga for a new synthetic graphite facility, significantly boosting its production capacity and local employment.

CurveBeam AI Limited reported a $4.367 million net operating cash outflow for Q3 2025 but anticipates a significant improvement in cash flow driven by device installations and customer receipts, with no immediate plans for capital raising.

Tryptamine Therapeutics has secured a landmark agreement with Swinburne University to initiate the first clinical trial of its IV-infused psilocin formulation TRP-8803 for Binge Eating Disorder, aiming to build on promising Phase 2a data.

Ecofibre Limited reported a $2.2 million operating cash outflow in 3Q25 with total cash at $1.3 million, highlighting mixed progress across its business units and a pressing need to monetise assets to sustain operations.